Literature DB >> 460045

Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group.

J Z Finklestein, M R Klemperer, A Evans, I Bernstein, S Leikin, S McCreadie, J Grosfeld, R Hittle, J Weiner, H Sather, D Hammond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 460045     DOI： 10.1002/mpo.2950060211

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  14 in total

1.  Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.

Authors:  S L Cohn; A W Rademaker; H R Salwen; W A Franklin; F Gonzales-Crussi; S T Rosen; K D Bauer
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

2.  Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Authors:  Mark A Applebaum; Tara O Henderson; Sang Mee Lee; Navin Pinto; Samuel L Volchenboum; Susan L Cohn
Journal:  Pediatr Blood Cancer       Date:  2014-09-23       Impact factor: 3.167

3.  Management of Wilms' tumor and neuroblastoma.

Authors:  P Mehta; T Vats
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

Review 4.  Neuroblastoma.

Authors:  S C Gulati; R Vega; L Gandola; C Gulati; J Yopp; R O'Reilly; B Clarkson
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

5.  High dose melphalan in children with advanced malignant disease. A pharmacokinetic study.

Authors:  J Ninane; R Baurain; A de Selys; A Trouet; G Cornu
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

Authors:  J Ninane; J Pritchard; J S Malpas
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

7.  Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement.

Authors:  J Ninane; J Pritchard; P H Morris Jones; J R Mann; J S Malpas
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

8.  The strategy to treat disseminated neuroblastoma utilizing bone marrow transplantation: what is the surgeon's role?

Authors:  S Yokoyama; H Hirakawa; J Soeda; S Ueno; T Tajima; T Mitomi; H Yabe; M Yabe; S Kato
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.

Authors:  O Hartmann; C Kalifa; E Benhamou; C Patte; F Flamant; C Jullien; F Beaujean; J Lemerle
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Medulloblastoma metastatic to the marrow. Report of four cases and review of the literature.

Authors:  C D Spencer; R B Weiss; J Van Eys; P Cohen; B Edwards
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.